Tags: Apalutamide
Hem/Onc News
Apalutamide Approved for Use in Nonmetastatic Castration-Resistant Prostate Cancer The US Food and Drug Administration (FDA) on February 14 approved the next-generation androgen receptor inhibitor apalutamide […]